Unlock instant, AI-driven research and patent intelligence for your innovation.

Imidazole ring modified acid-sensitive polycarbonate material as well as preparation and application thereof

A polycarbonate, acid-sensitive technology, applied in the field of polycarbonate materials and its preparation and its application as a drug carrier in drug delivery, can solve the problems of increasing toxic and side effects, and achieve simple preparation, good stability, good Antitumor Prospect Effect

Active Publication Date: 2018-12-21
沈阳信达泰康医药科技有限公司
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Nowadays, most antineoplastic drugs are poorly soluble drugs. Generally, some excipients are added to improve their water solubility, but at the same time, some toxic and side effects will also be increased. Therefore, it is of great significance to solve the problem of poorly soluble drugs by means of preparations, so the design is better. The drug delivery vehicle is meaningful

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Imidazole ring modified acid-sensitive polycarbonate material as well as preparation and application thereof
  • Imidazole ring modified acid-sensitive polycarbonate material as well as preparation and application thereof
  • Imidazole ring modified acid-sensitive polycarbonate material as well as preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] m PEG-PCC-Im preparation.

[0042] (a) Monomer preparation: 45.0g (0.338mol) 2,2-dimethylolpropionic acid (I), equimolar mass KOH (88%, 21.5g, 0.338mol) was dissolved in a 500ml eggplant-shaped bottle of DMF250ml , reacted at 100°C for 2h, and stirred vigorously until all the crystals were dissolved. 46ml (0.404mol) of excess benzyl chloride was slowly added dropwise to the eggplant-shaped flask with stirring. It was refluxed and stirred at 100°C for 18 hours. After filtration, distill out DMF from the filtrate under reduced pressure at 70-100°C. Dissolve the product with 600ml of organic phase (n-hexane-ethyl acetate 1:1) and 200ml of aqueous phase, and separate the layers. Keep the upper organic phase and wash it twice with 200ml distilled water. Pour the organic phase into a beaker filled with a large amount of anhydrous sodium sulfate and stir for 1 h to remove residual water. filter. The filtrate was rotary evaporated to obtain a yellow solid. Heat an approp...

Embodiment 2

[0052] 2.1 Preparation of drug-loaded micelles:

[0053] Medicine (docetaxel) and the carrier (mPEG) prepared in embodiment 1 113 -PCC 32 -Im) (1:4, w / w) the carrier is dissolved in dichloromethane at the same time, drop into the water phase and stir (500rpm) for 5min, probe ultrasonic (400W, 3min) under ice bath, stir at 500rpm for 12h to remove the organic solvent .

[0054] 2.2 Screening of drug to carrier ratio (weight ratio):

[0055] Table 1. Comparison of micellar properties for different drug to carrier ratios

[0056]

[0057] The results showed that: when the ratio of drug to carrier was 1:1-1:4, the drug loading capacity and encapsulation efficiency were increased, and when the ratio of drug to carrier was 1:3-1:4, the The drug dosage can reach more than 80%, and the encapsulation rate can reach more than 15%.

[0058] 2.3 Screening of the ratio (v / v) of organic phase (dichloromethane) to aqueous phase:

[0059] Control other conditions unchanged, prepare d...

Embodiment 3

[0093] Determination of critical micelle concentration of mPEG-PCC-Im polymer:

[0094]The determination of critical micelle concentration widely adopts pyrene fluorescent probe method. Pyrene is a fat-soluble fluorescent probe with weak fluorescence in polar environment and strong fluorescence in nonpolar environment. When there are micelles or hydrophobic regions in the polar solvent, pyrene will spontaneously transfer from the polar environment to the non-polar environment, resulting in enhanced fluorescence. Usually, this characteristic of pyrene is reflected by the ratio of the intensity of the first excitation peak to the third excitation peak. When this ratio increases significantly, it means that pyrene migrates from a polar environment to a non-polar environment, that is, micelles or hydrophobic region generated.

[0095] will be 6×10 -6 The mol / L pyrene solution in absolute ethanol was added to a 20mL stoppered flask, and the absolute ethanol was removed by drying...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of new accessories and new dosage forms of a pharmaceutical preparation, relates to an imidazole ring modified acid-sensitive polycarbonate material as well as preparation and application thereof, and specifically relates to a polycarbonate material with acid sensitivity and long circulation as well as preparation and application thereof as a drug carrier in drugtransfer. The structure of the imidazole ring modified acid-sensitive amphiphilic polycarbonate material is shown in the description, wherein m and n are described in the Claims and the Description.

Description

technical field [0001] The invention belongs to the field of new auxiliary materials and new dosage forms of pharmaceutical preparations, and relates to an acid-sensitive polycarbonate material modified with an imidazole ring and its preparation and application, in particular to an acid-sensitive, long-cycle polycarbonate material and its Preparation and its use as a drug carrier in drug delivery. Background technique [0002] Nowadays, most antineoplastic drugs are poorly soluble drugs. Generally, some excipients are added to improve their water solubility, but at the same time, some toxic and side effects will also be increased. Therefore, it is of great significance to solve the problem of poorly soluble drugs by means of preparations, so the design is better. The drug delivery vehicle is meaningful. [0003] In recent years, a large number of experimental results have illustrated the advantages of nano-preparations as drug carriers, including small particle size, lower ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C08G64/18C08G64/42C08G64/30A61K47/34A61K9/107A61K45/00A61P35/00
CPCA61K45/00A61K47/34A61P35/00A61K9/1075C08G64/183C08G64/30C08G64/42Y02P20/55
Inventor 张天骄杨育文赵龙山
Owner 沈阳信达泰康医药科技有限公司